Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-654-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1967
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 967
- Report date:
- 1967
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- 7 days instead of 14 days observation
- Principles of method if other than guideline:
- Single oral application to mice and calculation of 7 day LD50
Study performance before implementation of corresponding international guidelines, however study performance is comparable to recent guidelines to great extent. - GLP compliance:
- no
- Remarks:
- study performance before implementation of GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Reaction products of ricinoleic acid with 2-aminoethanol and maleic acid and sodium hydrogensulfite
- EC Number:
- 939-654-5
- Molecular formula:
- Molecular formula cannot be given as the substance is a mixture
- IUPAC Name:
- Reaction products of ricinoleic acid with 2-aminoethanol and maleic acid and sodium hydrogensulfite
- Test material form:
- other: liquid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Institut für industrielle und biologische Forschung, GmbH, Köln
- Age at study initiation: Not provided
- Weight at study initiation: Median weight of 23.7 g
- Fasting period before study: Approximately 17-20 hours
- Housing: Prior to the application in Plastibox cages (42x28x17 cm3) in groups of 35 animals on vermiculite. After application in Makrolon cages on wire roasting over vermiculite.
- Diet (e.g. ad libitum): Altromin R, pellet diameter 8-9mm, supplier: Altromin GmbH
- Water (e.g. ad libitum): Tap water, ad libitum
- Acclimation period: Not provided
ENVIRONMENTAL CONDITIONS
- Temperature (°C): ca. 21°C
- Humidity (%): ca. 70%
- Air changes (per hr): Not provided
- Photoperiod (hrs dark / hrs light): Not provided
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 0.0464, 0.215, 0.464, 1.00, 1.00 and 1.00 (mL/mL) at the dose levels of 1.00, 4.64, 10.0, 21.5, 31.6 and 46.4 mL/kg bw, respectively
MAXIMUM DOSE VOLUME APPLIED: 46.4 mL/kg bw or rather 1.10 mL/mouse - Doses:
- 1.00 mL/kg bw; 4.64 mL/kg bw ; 10.0 mL/kg bw ; 21.5 mL/kg bw ; 31.6 mL/kg bw and 46.4 mL/kg bw
- No. of animals per sex per dose:
- 10 for the 1.00; 4.64; and 10.0 mL/kg dose
20 for the 21.5 and 46.4 mL/kg dose
16 for the 31.6 mL/kg dose - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 7 days
- Frequency of observations and weighing: The mice were observed after application about 8 hours long at short intervals. Further assessments were performed several times daily until 7 days after application.
- Necropsy of survivors performed: yes
- Other examinations performed: vitality, pain reflex, cyanosis, breathing, corneal reflex, lid wide, exophtalmus, sound sensitivity, shaky walking, abdominal position, side position, running motion, clonic-tonic convulsions, ophistotonos, defecation; necropsy of deceased animals - Statistics:
- The quantitative evaluation of the lethality data was performed by graphical determination of the LD50 7 days after application, in the probability grid with logarithmic shared X-axis, when using confidence limits.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 28.7 mL/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: LD50 as reported in study report referring to the test substance as delivered by the sponsor
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 11 000 mg/kg bw
- Based on:
- other: solid content
- Remarks on result:
- other: Recalculated LD50 referring to solid content of 39% (according to producer information) and an assumed density of roughly 1
- Mortality:
- Up to and including the dose level of 10.0 mL/kg bw no animal died.
In the dose group of 21.5 mL/kg bw 5% (1/20) of the animals was found death two days p.a.. In the dose groups of 31.6 and 46.4 mL/kg bw 88% (14/16) and 100% (20/20) of the animals died within 24 hours or 6 hours p.a. respectively. - Clinical signs:
- other: Especially in the doses 21.5; 31.6 and 46.6 mL/kg quiet, apathetic behavior, closed eyes, diarrhea with soft faeces and decreased sound sensitivity were observed. Also in the 10.0 mL/kg dose group a number of animals showed diarrhea ( occurrence ca. 2 hou
- Gross pathology:
- In the stomach and small intestine of mice who died, dark reddish-brown slimy liquid was determined. The mucous membranes were dark red and translucent, and showed macroscopic signs of irritation, especially the main gastric membranes. Intubation injuries were not found.
- Other findings:
- - Organ weights: no data
- Histopathology: no data
- Potential target organs: no data
- Other observations: no data
Any other information on results incl. tables
Table 1. Lethality, chronological categorization (summed up, %)
Experimental Period |
Dosis (mL/kg) |
|||||
0 bis |
1.00 |
4.64 |
10.0 |
21.5 |
31.6 |
46.4 |
20 min |
|
|
|
|
6 |
|
40 min |
|
|
|
|
13 |
35 |
60 min |
|
|
|
|
19 |
60 |
2 h |
|
|
|
|
44 |
70 |
4 h |
|
|
|
|
50 |
90 |
6 h |
|
|
|
|
|
100 |
24 h |
0 |
0 |
0 |
0 |
88 |
100 |
2 d |
|
|
|
5 |
|
|
3 d |
|
|
|
|
|
|
4 d |
|
|
|
|
|
|
5 d |
|
|
|
|
|
|
6 d |
|
|
|
|
|
|
7 d |
0 |
0 |
0 |
5 |
88 |
100 |
Number of mice used |
10 |
10 |
10 |
20 |
16 |
20 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LD50 at 7 days was 28.7mL/kg. The LD50 for an observation period of 24 hours did practically not differ from the previous value. Recalculated LD50 referring to solid content of 39% (according to producer information) and an assumed density of roughly 1 was calculated to be ca. 11000 mg/kg bw.
- Executive summary:
Acute oral toxicity (LD50) of the test item was examined by gavage in male NMRI mice at doses of 1, 4.64, 10, 21.5, 31.6 and 46.4 mL/kg bw. There were no pronounced , specific toxic behavioral symptoms registered at the lower doses of 1 and 4.64 mL/kg bw. At doses ≥10 ml/kg diarrhea was seen. The died mice showed irritation of the mucous membranes of the stomach and small intestine. At the higher doses (21.5, 31.6 and 4.64 mL/kg bw/day), quiet apathetic behaviour, closed eyes and decreased sound activity were also observed.
The LD50 at 7 days was 28.7 mL/kg. Recalculated LD50 referring to solid content of 39% (according to producer information) and an assumed density of roughly 1 was calculated to be ca. 11000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
